Browsing Tag
Beeline Medicines
1 post
Beeline Medicines advances afimetoran toward pivotal lupus trials after strong Phase 2 results
Beeline Medicines' afimetoran trial success puts its $426.3 million-backed lupus strategy in focus. Explore the pivotal plans and risks ahead.